A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

CanAssist Breast (CAB), a prognostic test uses immunohistochemistry (IHC) approach coupled with artificial intelligence-based machine learning algorithm for prognosis of early-stage hormone-receptor positive, HER2/neu negative breast cancer patients. It was developed and validated in an Indian cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunda, Aparna, Basavaraj, Chetana, Serkad V, Chandra Prakash, Adinarayan, Manjula, Kolli, Ramu, Siraganahalli Eshwaraiah, Mallikarjuna, Saura, Cristina, Ruiz, Fiorella, Gomez, Patricia, Peg, Vicente, Jimenez, Jose, Sprung, Susanne, Fiegl, Heidi, Brunner, Christine, Egle, Daniel, Bhattacharyya, GS, Bakre, Manjiri M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892025/
https://www.ncbi.nlm.nih.gov/pubmed/35245746
http://dx.doi.org/10.1016/j.breast.2022.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892025/
https://www.ncbi.nlm.nih.gov/pubmed/35245746
http://dx.doi.org/10.1016/j.breast.2022.02.010

Ejemplares similares